Can higher uric acid cause endothelial dysfunction and raise cardiovascular risk?

An extensive body of clinical and basic science research confirms that elevated uric acid (hyperuricemia) is not merely a marker of metabolic dysfunction, but a direct driver of vascular pathology. This occurs through a cascade of cellular events that lead to endothelial dysfunction and heightened cardiovascular risk.

Clinical and Pathological Mechanisms

• Intracellular Oxidative Stress: Soluble uric acid enters endothelial cells and acts as a potent pro-oxidant. It activates NADPH oxidase (notably via p47phox subunit translocation) and induces mitochondrial dysfunction. These pathways significantly elevate reactive oxygen species (ROS) production, damaging cellular lipids, proteins, and DNA.
• Endothelial Inflammation: High uric acid levels trigger pro-inflammatory pathways within the vasculature. Specifically, it activates the HMGB1/RAGE axis and NF-κB signaling, upregulating key inflammatory cytokines (such as IL-6 and TNF-α) and vascular adhesion molecules (including ICAM-1 and VCAM-1). This encourages leukocyte and monocyte adhesion to the vessel wall, accelerating atherogenesis.
• Impaired Nitric Oxide (NO) Signaling: Uric acid directly compromises NO bioavailability—the cornerstone of endothelial health. It impairs endothelial nitric oxide synthase (eNOS) by disrupting its interaction with calmodulin, promoting inhibitory phosphorylation (at Thr495), and blocking insulin-stimulated Akt-eNOS activation. Furthermore, extracellular uric acid directly scavenges and inactivates existing NO molecules, severely impairing vasodilation.
• Coronary Calcification and Structural Damage: This triad of oxidative stress, inflammation, and depleted NO drives the transition from functional impairment to structural arterial damage. Endothelial dysfunction promotes vascular smooth muscle cell proliferation and lipid retention, accelerating coronary artery calcification (CAC)—a key radiological marker of advanced atherosclerotic burden and future cardiovascular event risk.

Clinical Implications and Cardiovascular Risk

• Predictive Value of Endothelial Function: Endothelial dysfunction, clinically measured via brachial flow-mediated dilation (FMD), is a highly sensitive predictor of future cardiovascular events. Prospective studies indicate that for every standard deviation decrease in FMD, the risk of experiencing a major adverse cardiovascular event (MACE) rises significantly (corresponding to a hazard ratio of 0.84 per SD increase).
• Uric Acid as a Cardiovascular Risk Predictor: Epidemiological data consistently associate elevated serum uric acid levels with a higher prevalence, burden, and progression rate of coronary artery calcification.

Bottom line

Elevated uric acid levels directly injure the vascular lining by promoting oxidative stress, activating inflammatory pathways, and disrupting nitric oxide signaling. This functional endothelial impairment escalates into structural vascular damage, such as coronary artery calcification, significantly increasing the risk of future cardiovascular events.